The effect of cost on adherence to prescription medications in Canada
- PMID: 22249979
- PMCID: PMC3281154
- DOI: 10.1503/cmaj.111270
The effect of cost on adherence to prescription medications in Canada
Abstract
Background: Many patients do not adhere to treatment because they cannot afford their prescription medications, putting them at increased risk of adverse health outcomes. We determined the prevalence of cost-related nonadherence and investigated its associated characteristics, including whether a person has drug insurance.
Methods: Using data from the 2007 Canada Community Health Survey, we analyzed the responses of 5732 people who answered questions about cost-related nonadherence to treatment. We determined the national prevalence of cost-related nonadherence and used logistic regression to evaluate the association between cost-related nonadherence and a series of demographic and socioeconomic variables, including province of residence, age, sex, household income, health status and having drug insurance.
Results: Cost-related nonadherence was reported by 9.6% (95% confidence interval [CI] 8.5%-10.6%) of Canadians who had received a prescription in the past year. In our adjusted model, we found that people in poor health (odds ratio [OR] 2.64, 95% CI 1.77-3.94), those with lower income (OR 3.29, 95% CI 2.03-5.33), those without drug insurance (OR 4.52, 95% CI 3.29-6.20) and those who live in British Columbia (OR 2.56, 95% CI 1.49-4.42) were more likely to report cost-related nonadherence. Predicted rates of cost-related nonadherence ranged from 3.6% (95% CI 2.4-4.5) among people with insurance and high household incomes to 35.6% (95% CI 26.1%-44.9%) among people with no insurance and low household incomes.
Interpretation: About 1 in 10 Canadians who receive a prescription report cost-related nonadherence. The variability in insurance coverage for prescription medications appears to be a key reason behind this phenomenon.
Figures

Comment in
-
Leadership on prescription drugs needed.CMAJ. 2012 Jul 10;184(10):1175. doi: 10.1503/cmaj.112-2050. CMAJ. 2012. PMID: 22778162 Free PMC article. No abstract available.
Similar articles
-
Cost-related prescription nonadherence in the United States and Canada: a system-level comparison using the 2007 International Health Policy Survey in Seven Countries.Clin Ther. 2009 Jan;31(1):213-9. doi: 10.1016/j.clinthera.2009.01.006. Clin Ther. 2009. PMID: 19243719
-
A cross-national study of prescription nonadherence due to cost: data from the Joint Canada-United States Survey of Health.Clin Ther. 2006 Aug;28(8):1217-1224. doi: 10.1016/j.clinthera.2006.07.009. Clin Ther. 2006. PMID: 16982299
-
Out-of-pocket spending on drugs and pharmaceutical products and cost-related prescription non-adherence among Canadians with chronic disease.Health Rep. 2016 Jun 15;27(6):3-8. Health Rep. 2016. PMID: 27305075
-
Cost-related medication nonadherence in Canada: a systematic review of prevalence, predictors, and clinical impact.Syst Rev. 2021 Jan 6;10(1):11. doi: 10.1186/s13643-020-01558-5. Syst Rev. 2021. PMID: 33407875 Free PMC article.
-
Cost-related nonadherence to prescription medications in Canada: a scoping review.Patient Prefer Adherence. 2018 Sep 6;12:1699-1715. doi: 10.2147/PPA.S170417. eCollection 2018. Patient Prefer Adherence. 2018. PMID: 30233150 Free PMC article.
Cited by
-
A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada.Healthc Policy. 2016 Aug;12(1):18-36. Healthc Policy. 2016. PMID: 27585023 Free PMC article.
-
Patterns of borrowing to finance out-of-pocket prescription drug costs in Canada: a descriptive analysis.CMAJ Open. 2018 Nov 19;6(4):E544-E550. doi: 10.9778/cmajo.20180063. Print 2018 Oct-Dec. CMAJ Open. 2018. PMID: 30459172 Free PMC article.
-
Herpes zoster vaccine (HZV): utilization and coverage 2009 - 2013, Alberta, Canada.BMC Public Health. 2014 Oct 23;14:1098. doi: 10.1186/1471-2458-14-1098. BMC Public Health. 2014. PMID: 25342438 Free PMC article.
-
Financial barriers and adverse clinical outcomes among patients with cardiovascular-related chronic diseases: a cohort study.BMC Med. 2017 Feb 15;15(1):33. doi: 10.1186/s12916-017-0788-6. BMC Med. 2017. PMID: 28196524 Free PMC article.
-
Barriers to adherence to antiretroviral therapy: identifying priority areas for people with HIV and healthcare professionals.Int J STD AIDS. 2023 Sep;34(10):677-686. doi: 10.1177/09564624231169329. Epub 2023 Apr 27. Int J STD AIDS. 2023. PMID: 37113058 Free PMC article.
References
-
- Morgan S, Raymond C, Mooney D, et al. The Canadian Rx atlas. Vancouver (BC): Centre for Health Services and Policy Research, University of British Columbia; 2008
-
- Canadian Institute for Health Information Health care in Canada, 2008. Ottawa (ON): The Institute; 2008
-
- Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487–97 - PubMed
-
- Lexchin J, Grootendorst P. Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence. Int J Health Serv 2004;34:101–22 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous